Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
2000 2
2001 4
2002 3
2004 3
2005 2
2006 4
2007 8
2008 5
2009 4
2010 9
2011 10
2012 8
2013 9
2014 7
2015 5
2016 10
2017 4
2018 1
2019 8
2020 6
2021 9
2022 10
2023 13

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Results by year

Filters applied: . Clear all
Page 1
PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia.
Alshamleh I, Kurrle N, Makowka P, Bhayadia R, Kumar R, Süsser S, Seibert M, Ludig D, Wolf S, Koschade SE, Stoschek K, Kreitz J, Fuhrmann DC, Toenges R, Notaro M, Comoglio F, Schuringa JJ, Berg T, Brüne B, Krause DS, Klusmann JH, Oellerich T, Schnütgen F, Schwalbe H, Serve H. Alshamleh I, et al. Among authors: schuringa jj. Leukemia. 2023 Dec;37(12):2367-2382. doi: 10.1038/s41375-023-02041-5. Epub 2023 Nov 7. Leukemia. 2023. PMID: 37935978 Free PMC article.
Clonal Hematopoiesis Defined by Somatic Mutations Infrequently Co-occurs With Mosaic Loss of the Y Chromosome in a Population-based Cohort.
Kamphuis P, van Zeventer IA, de Graaf AO, Genovese G, Salzbrunn JB, Dinmohamed AG, van der Reijden BA, Schuringa JJ, Jansen JH, Huls G. Kamphuis P, et al. Among authors: schuringa jj. Hemasphere. 2023 Sep 13;7(10):e956. doi: 10.1097/HS9.0000000000000956. eCollection 2023 Oct. Hemasphere. 2023. PMID: 37720253 Free PMC article. No abstract available.
Clonal hematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based controls.
Salzbrunn JB, van Zeventer IA, de Graaf AO, Kamphuis P, van Bergen MGJM, van Sleen Y, van der Reijden BA, Schuringa JJ, Brouwer E, Diepstra A, Jansen JH, Huls G. Salzbrunn JB, et al. Among authors: schuringa jj. Rheumatology (Oxford). 2023 Aug 26:kead435. doi: 10.1093/rheumatology/kead435. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37632778 No abstract available.
Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold.
Griessinger E, Pereira-Martins D, Nebout M, Bosc C, Saland E, Boet E, Sahal A, Chiche J, Debayle D, Fleuriot L, Pruis M, De Mas V, Vergez F, Récher C, Huls G, Sarry JE, Schuringa JJ, Peyron JF. Griessinger E, et al. Among authors: schuringa jj. Cancer Res. 2023 Aug 1;83(15):2461-2470. doi: 10.1158/0008-5472.CAN-23-1006. Cancer Res. 2023. PMID: 37272750 Free PMC article.
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism.
Weinhäuser I, Pereira-Martins DA, Almeida LY, Hilberink JR, Silveira DRA, Quek L, Ortiz C, Araujo CL, Bianco TM, Lucena-Araujo A, Mota JM, Hogeling SM, Sternadt D, Visser N, Diepstra A, Ammatuna E, Huls G, Rego EM, Schuringa JJ. Weinhäuser I, et al. Among authors: schuringa jj. Sci Adv. 2023 Apr 14;9(15):eadf8522. doi: 10.1126/sciadv.adf8522. Epub 2023 Apr 14. Sci Adv. 2023. PMID: 37058562 Free article.
Sex Differences in the Spectrum of Clonal Hematopoiesis.
Kamphuis P, van Zeventer IA, de Graaf AO, Salzbrunn JB, van Bergen MGJM, Dinmohamed AG, van der Reijden BA, Schuringa JJ, Jansen JH, Huls G. Kamphuis P, et al. Among authors: schuringa jj. Hemasphere. 2023 Jan 24;7(2):e832. doi: 10.1097/HS9.0000000000000832. eCollection 2023 Feb. Hemasphere. 2023. PMID: 36713353 Free PMC article. No abstract available.
Abnormal Platelet Counts and Clonal Hematopoiesis in the General Population.
Kamphuis P, van Bergen MGJM, van Zeventer IA, de Graaf AO, Dinmohamed AG, Salzbrunn JB, Schuringa JJ, van der Reijden BA, Huls G, Jansen JH. Kamphuis P, et al. Among authors: schuringa jj. Hemasphere. 2023 Jan 5;7(1):e821. doi: 10.1097/HS9.0000000000000821. eCollection 2023 Jan. Hemasphere. 2023. PMID: 36698617 Free PMC article.
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy.
Lima K, Pereira-Martins DA, de Miranda LBL, Coelho-Silva JL, Leandro GDS, Weinhäuser I, Cavaglieri RC, Leal AM, da Silva WF, Lange APAL, Velloso EDRP, Griessinger E, Hilberink JR, Ammatuna E, Huls G, Schuringa JJ, Rego EM, Machado-Neto JA. Lima K, et al. Among authors: schuringa jj. Blood Cancer J. 2022 Nov 9;12(11):151. doi: 10.1038/s41408-022-00747-w. Blood Cancer J. 2022. PMID: 36347832 Free PMC article.
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia.
Pereira-Martins DA, Coelho-Silva JL, Weinhäuser I, Franca-Neto PL, Silveira DR, Ortiz C, Moreira-Aguiar A, Lima MM, Koury LC, de Melo RA, Glória AB, Fagundes EM, Lino BK, Pagnano K, Bittencourt R, Nunes E, Traina F, Figueiredo-Pontes L, Keating A, Tallman MS, Ribeiro RC, Dilon R, Ganser A, Sanz MA, Berliner N, Valk P, Löwenberg B, Ottone T, Noguera NI, Voso MT, Paoloni F, Fazi P, Ammatuna E, Huls G, Schuringa JJ, Rego EM, Lucena-Araujo AR. Pereira-Martins DA, et al. Among authors: schuringa jj. Br J Haematol. 2023 Jan;200(2):170-174. doi: 10.1111/bjh.18510. Epub 2022 Oct 20. Br J Haematol. 2023. PMID: 36263593
Crosstalk between AML and stromal cells triggers acetate secretion through the metabolic rewiring of stromal cells.
Vilaplana-Lopera N, Cuminetti V, Almaghrabi R, Papatzikas G, Rout AK, Jeeves M, González E, Alyahyawi Y, Cunningham A, Erdem A, Schnütgen F, Raghavan M, Potluri S, Cazier JB, Schuringa JJ, Reed MAC, Arranz L, Günther UL, Garcia P. Vilaplana-Lopera N, et al. Among authors: schuringa jj. Elife. 2022 Sep 2;11:e75908. doi: 10.7554/eLife.75908. Elife. 2022. PMID: 36052997 Free PMC article.
Dietary methionine starvation impairs acute myeloid leukemia progression.
Cunningham A, Erdem A, Alshamleh I, Geugien M, Pruis M, Pereira-Martins DA, van den Heuvel FAJ, Wierenga ATJ, Ten Berge H, Dennebos R, van den Boom V, Hogeling SM, Weinhäuser I, Knops R, de Blaauw P, Heiner-Fokkema MR, Woolthuis C, Günther UL, Rego EM, Martens JHA, Jansen JH, Schwalbe H, Huls G, Schuringa JJ. Cunningham A, et al. Among authors: schuringa jj. Blood. 2022 Nov 10;140(19):2037-2052. doi: 10.1182/blood.2022017575. Blood. 2022. PMID: 35984907 Free article.
Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals.
van Zeventer IA, de Graaf AO, Koorenhof-Scheele TN, van der Reijden BA, van der Klauw MM, Dinmohamed AG, Diepstra A, Schuringa JJ, Malcovati L, Huls G, Jansen JH. van Zeventer IA, et al. Among authors: schuringa jj. Blood Adv. 2022 Jul 26;6(14):4174-4184. doi: 10.1182/bloodadvances.2021006755. Blood Adv. 2022. PMID: 35561316 Free PMC article.
Inhibition of the succinyl dehydrogenase complex in acute myeloid leukemia leads to a lactate-fuelled respiratory metabolic vulnerability.
Erdem A, Marin S, Pereira-Martins DA, Geugien M, Cunningham A, Pruis MG, Weinhäuser I, Gerding A, Bakker BM, Wierenga ATJ, Rego EM, Huls G, Cascante M, Schuringa JJ. Erdem A, et al. Among authors: schuringa jj. Nat Commun. 2022 Apr 19;13(1):2013. doi: 10.1038/s41467-022-29639-0. Nat Commun. 2022. PMID: 35440568 Free PMC article.
The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia.
Erdem A, Marin S, Pereira-Martins DA, Cortés R, Cunningham A, Pruis MG, de Boer B, van den Heuvel FAJ, Geugien M, Wierenga ATJ, Brouwers-Vos AZ, Rego EM, Huls G, Cascante M, Schuringa JJ. Erdem A, et al. Among authors: schuringa jj. Nat Commun. 2022 Mar 1;13(1):1105. doi: 10.1038/s41467-022-28737-3. Nat Commun. 2022. PMID: 35232995 Free PMC article.
The EHA Research Roadmap: Normal Hematopoiesis.
Jaffredo T, Balduini A, Bigas A, Bernardi R, Bonnet D, Canque B, Charbord P, Cumano A, Delwel R, Durand C, Fibbe W, Forrester L, de Franceschi L, Ghevaert C, Gjertsen B, Gottgens B, Graf T, Heidenreich O, Hermine O, Higgs D, Kleanthous M, Klump H, Kouskoff V, Krause D, Lacaud G, Celso CL, Martens JHA, Méndez-Ferrer S, Menendez P, Oostendorp R, Philipsen S, Porse B, Raaijmakers M, Robin C, Stunnenberg H, Theilgaard-Mönch K, Touw I, Vainchenker W, Corrons JV, Yvernogeau L, Schuringa JJ. Jaffredo T, et al. Among authors: schuringa jj. Hemasphere. 2021 Nov 30;5(12):e669. doi: 10.1097/HS9.0000000000000669. eCollection 2021 Dec. Hemasphere. 2021. PMID: 34853826 Free PMC article. No abstract available.
The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells.
de Almeida LY, Pereira-Martins DA, Weinhäuser I, Ortiz C, Cândido LA, Lange AP, De Abreu NF, Mendonza SES, de Deus Wagatsuma VM, Do Nascimento MC, Paiva HH, Alves-Paiva RM, Bonaldo CCOM, Nascimento DC, Alves-Filho JC, Scheucher PS, Lima ASG, Schuringa JJ, Ammantuna E, Ottone T, Noguera NI, Araujo CL, Rego EM. de Almeida LY, et al. Among authors: schuringa jj. Front Oncol. 2021 Sep 28;11:686445. doi: 10.3389/fonc.2021.686445. eCollection 2021. Front Oncol. 2021. PMID: 34650910 Free PMC article.
The USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemia.
Maat H, Atsma TJ, Hogeling SM, Rodríguez López A, Jaques J, Olthuis M, de Vries MP, Gravesteijn C, Brouwers-Vos AZ, van der Meer N, Datema S, Salzbrunn J, Huls G, Baas R, Martens JHA, van den Boom V, Schuringa JJ. Maat H, et al. Among authors: schuringa jj. iScience. 2021 Apr 16;24(5):102435. doi: 10.1016/j.isci.2021.102435. eCollection 2021 May 21. iScience. 2021. PMID: 34113809 Free PMC article.
The Expression of NTAL and Its Protein Interactors Is Associated With Clinical Outcomes in Acute Myeloid Leukemia.
Thomé CH, Ferreira GA, Pereira-Martins DA, Augusto Dos Santos G, Almeida-Silveira DR, Weinhäuser I, Antônio de Souza G, Houtsma R, Schuringa JJ, Rego EM, Faça VM. Thomé CH, et al. Among authors: schuringa jj. Mol Cell Proteomics. 2021;20:100091. doi: 10.1016/j.mcpro.2021.100091. Epub 2021 May 7. Mol Cell Proteomics. 2021. PMID: 33971369 Free PMC article.
MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model.
Pereira-Martins DA, Weinhäuser I, Coelho-Silva JL, França-Neto PL, Almeida LY, Bianco TM, Silva CL, França RF, Traina F, Rego EM, Schuringa JJ, Lucena-Araujo AR. Pereira-Martins DA, et al. Among authors: schuringa jj. Cell Death Dis. 2021 Apr 6;12(4):371. doi: 10.1038/s41419-021-03604-z. Cell Death Dis. 2021. PMID: 33824267 Free PMC article.
Pretransplantation MRD in Older Patients With AML After Treatment With Decitabine or Conventional Chemotherapy.
Hilberink JR, Morsink LM, van der Velden WJFM, Mulder AB, Hazenberg CLE, de Groot M, Choi G, Schuringa JJ, Meijer K, Blijlevens NMA, Ammatuna E, Huls G. Hilberink JR, et al. Among authors: schuringa jj. Transplant Cell Ther. 2021 Mar;27(3):246-252. doi: 10.1016/j.jtct.2020.12.014. Epub 2020 Dec 17. Transplant Cell Ther. 2021. PMID: 33781523 Free article.
Dissecting Clonal Heterogeneity in AML.
Schuringa JJ, Bonifer C. Schuringa JJ, et al. Cancer Cell. 2020 Dec 14;38(6):782-784. doi: 10.1016/j.ccell.2020.11.011. Cancer Cell. 2020. PMID: 33321087 Free article.
Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia.
Weinhäuser I, Pereira-Martins DA, Ortiz C, Silveira DR, Simões LAA, Bianco TM, Araujo CL, Koury LC, Melo RAM, Bittencourt RI, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria AB, Kerbauy F, Chauffaille ML, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Ammatuna E, Lucena-Araujo AR, Schuringa JJ, Rego EM. Weinhäuser I, et al. Among authors: schuringa jj. Cancers (Basel). 2020 Oct 27;12(11):3134. doi: 10.3390/cancers12113134. Cancers (Basel). 2020. PMID: 33120864 Free PMC article.
Innovations, challenges, and minimal information for standardization of humanized mice.
Stripecke R, Münz C, Schuringa JJ, Bissig KD, Soper B, Meeham T, Yao LC, Di Santo JP, Brehm M, Rodriguez E, Wege AK, Bonnet D, Guionaud S, Howard KE, Kitchen S, Klein F, Saeb-Parsy K, Sam J, Sharma AD, Trumpp A, Trusolino L, Bult C, Shultz L. Stripecke R, et al. Among authors: schuringa jj. EMBO Mol Med. 2020 Jul 7;12(7):e8662. doi: 10.15252/emmm.201708662. Epub 2020 Jun 24. EMBO Mol Med. 2020. PMID: 32578942 Free PMC article. Review.
HIF1/2-exerted control over glycolytic gene expression is not functionally relevant for glycolysis in human leukemic stem/progenitor cells.
Wierenga ATJ, Cunningham A, Erdem A, Lopera NV, Brouwers-Vos AZ, Pruis M, Mulder AB, Günther UL, Martens JHA, Vellenga E, Schuringa JJ. Wierenga ATJ, et al. Among authors: schuringa jj. Cancer Metab. 2019 Dec 27;7:11. doi: 10.1186/s40170-019-0206-y. eCollection 2019. Cancer Metab. 2019. PMID: 31890203 Free PMC article.
The acute myeloid leukemia associated AML1-ETO fusion protein alters the transcriptome and cellular progression in a single-oncogene expressing in vitro induced pluripotent stem cell based granulocyte differentiation model.
Tijchon E, Yi G, Mandoli A, Smits JGA, Ferrari F, Heuts BMH, Wijnen F, Kim B, Janssen-Megens EM, Schuringa JJ, Martens JHA. Tijchon E, et al. Among authors: schuringa jj. PLoS One. 2019 Dec 23;14(12):e0226435. doi: 10.1371/journal.pone.0226435. eCollection 2019. PLoS One. 2019. PMID: 31869378 Free PMC article.
Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patients.
Hilberink J, Hazenberg C, van den Berg E, Mulder A, Schuringa JJ, van der Helm L, de Groot M, Choi G, de Bock GH, Vellenga E, Ammatuna E, Huls G. Hilberink J, et al. Among authors: schuringa jj. Leuk Res. 2019 May;80:33-39. doi: 10.1016/j.leukres.2019.03.004. Epub 2019 Mar 18. Leuk Res. 2019. PMID: 30954622 Free article. Clinical Trial.
Chromatin-Based Classification of Genetically Heterogeneous AMLs into Two Distinct Subtypes with Diverse Stemness Phenotypes.
Yi G, Wierenga ATJ, Petraglia F, Narang P, Janssen-Megens EM, Mandoli A, Merkel A, Berentsen K, Kim B, Matarese F, Singh AA, Habibi E, Prange KHM, Mulder AB, Jansen JH, Clarke L, Heath S, van der Reijden BA, Flicek P, Yaspo ML, Gut I, Bock C, Schuringa JJ, Altucci L, Vellenga E, Stunnenberg HG, Martens JHA. Yi G, et al. Among authors: schuringa jj. Cell Rep. 2019 Jan 22;26(4):1059-1069.e6. doi: 10.1016/j.celrep.2018.12.098. Cell Rep. 2019. PMID: 30673601 Free PMC article.
Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones.
de Boer B, Prick J, Pruis MG, Keane P, Imperato MR, Jaques J, Brouwers-Vos AZ, Hogeling SM, Woolthuis CM, Nijk MT, Diepstra A, Wandinger S, Versele M, Attar RM, Cockerill PN, Huls G, Vellenga E, Mulder AB, Bonifer C, Schuringa JJ. de Boer B, et al. Among authors: schuringa jj. Cancer Cell. 2018 Oct 8;34(4):674-689.e8. doi: 10.1016/j.ccell.2018.08.014. Epub 2018 Sep 20. Cancer Cell. 2018. PMID: 30245083 Free article.
Smart niche usage: release its fat and burn it!
Schuringa JJ. Schuringa JJ. Blood. 2017 Mar 9;129(10):1239-1240. doi: 10.1182/blood-2017-01-761551. Blood. 2017. PMID: 28280044 Free article. No abstract available.
Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based niches.
Antonelli A, Noort WA, Jaques J, de Boer B, de Jong-Korlaar R, Brouwers-Vos AZ, Lubbers-Aalders L, van Velzen JF, Bloem AC, Yuan H, de Bruijn JD, Ossenkoppele GJ, Martens AC, Vellenga E, Groen RW, Schuringa JJ. Antonelli A, et al. Among authors: schuringa jj. Blood. 2016 Dec 22;128(25):2949-2959. doi: 10.1182/blood-2016-05-719021. Epub 2016 Oct 12. Blood. 2016. PMID: 27733356 Free article.
The European Hematology Association Roadmap for European Hematology Research: a consensus document.
Engert A, Balduini C, Brand A, Coiffier B, Cordonnier C, Döhner H, de Wit TD, Eichinger S, Fibbe W, Green T, de Haas F, Iolascon A, Jaffredo T, Rodeghiero F, Salles G, Schuringa JJ; EHA Roadmap for European Hematology Research. Engert A, et al. Among authors: schuringa jj. Haematologica. 2016 Feb;101(2):115-208. doi: 10.3324/haematol.2015.136739. Epub 2016 Jan 27. Haematologica. 2016. PMID: 26819058 Free PMC article.
Non-canonical PRC1.1 Targets Active Genes Independent of H3K27me3 and Is Essential for Leukemogenesis.
van den Boom V, Maat H, Geugien M, Rodríguez López A, Sotoca AM, Jaques J, Brouwers-Vos AZ, Fusetti F, Groen RW, Yuan H, Martens AC, Stunnenberg HG, Vellenga E, Martens JH, Schuringa JJ. van den Boom V, et al. Among authors: schuringa jj. Cell Rep. 2016 Jan 12;14(2):332-46. doi: 10.1016/j.celrep.2015.12.034. Epub 2015 Dec 31. Cell Rep. 2016. PMID: 26748712 Free article.
The TAK1-NF-κB axis as therapeutic target for AML.
Bosman MC, Schepers H, Jaques J, Brouwers-Vos AZ, Quax WJ, Schuringa JJ, Vellenga E. Bosman MC, et al. Among authors: schuringa jj. Blood. 2014 Nov 13;124(20):3130-40. doi: 10.1182/blood-2014-04-569780. Epub 2014 Oct 6. Blood. 2014. PMID: 25287709 Free article.
A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis.
Woolthuis CM, Mulder AB, Verkaik-Schakel RN, Rosati S, Diepstra A, van den Berg E, Schuringa JJ, Vellenga E, Kluin PM, Huls G. Woolthuis CM, et al. Among authors: schuringa jj. Haematologica. 2013 Oct;98(10):1532-8. doi: 10.3324/haematol.2012.079806. Epub 2013 May 28. Haematologica. 2013. PMID: 23716555 Free PMC article.
The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis.
Osaki H, Walf-Vorderwülbecke V, Mangolini M, Zhao L, Horton SJ, Morrone G, Schuringa JJ, de Boer J, Williams O. Osaki H, et al. Among authors: schuringa jj. Leukemia. 2013 Jul;27(7):1461-8. doi: 10.1038/leu.2013.42. Epub 2013 Feb 13. Leukemia. 2013. PMID: 23403462
Nonredundant and locus-specific gene repression functions of PRC1 paralog family members in human hematopoietic stem/progenitor cells.
van den Boom V, Rozenveld-Geugien M, Bonardi F, Malanga D, van Gosliga D, Heijink AM, Viglietto G, Morrone G, Fusetti F, Vellenga E, Schuringa JJ. van den Boom V, et al. Among authors: schuringa jj. Blood. 2013 Mar 28;121(13):2452-61. doi: 10.1182/blood-2012-08-451666. Epub 2013 Jan 24. Blood. 2013. PMID: 23349393 Free article.
Cancer stem cell definitions and terminology: the devil is in the details.
Valent P, Bonnet D, De Maria R, Lapidot T, Copland M, Melo JV, Chomienne C, Ishikawa F, Schuringa JJ, Stassi G, Huntly B, Herrmann H, Soulier J, Roesch A, Schuurhuis GJ, Wöhrer S, Arock M, Zuber J, Cerny-Reiterer S, Johnsen HE, Andreeff M, Eaves C. Valent P, et al. Among authors: schuringa jj. Nat Rev Cancer. 2012 Nov;12(11):767-75. doi: 10.1038/nrc3368. Epub 2012 Oct 11. Nat Rev Cancer. 2012. PMID: 23051844 Review.
Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma.
Groen RW, Noort WA, Raymakers RA, Prins HJ, Aalders L, Hofhuis FM, Moerer P, van Velzen JF, Bloem AC, van Kessel B, Rozemuller H, van Binsbergen E, Buijs A, Yuan H, de Bruijn JD, de Weers M, Parren PW, Schuringa JJ, Lokhorst HM, Mutis T, Martens AC. Groen RW, et al. Among authors: schuringa jj. Blood. 2012 Jul 19;120(3):e9-e16. doi: 10.1182/blood-2012-03-414920. Epub 2012 May 31. Blood. 2012. PMID: 22653974 Free article.
Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML.
de Jonge HJ, Woolthuis CM, Vos AZ, Mulder A, van den Berg E, Kluin PM, van der Weide K, de Bont ES, Huls G, Vellenga E, Schuringa JJ. de Jonge HJ, et al. Among authors: schuringa jj. Leukemia. 2011 Dec;25(12):1825-33. doi: 10.1038/leu.2011.172. Epub 2011 Jul 15. Leukemia. 2011. PMID: 21760593 Clinical Trial.
Treatment strategies in acute myeloid leukemia.
Han LN, Zhou J, Schuringa JJ, Vellenga E. Han LN, et al. Among authors: schuringa jj. Chin Med J (Engl). 2011 May;124(9):1409-21. Chin Med J (Engl). 2011. PMID: 21740756 Review.
Tracing C/EBPα+ cells and their progeny.
Schuringa JJ. Schuringa JJ. Blood. 2010 Nov 18;116(20):4038-9. doi: 10.1182/blood-2010-09-306399. Blood. 2010. PMID: 21088140 Free article. No abstract available.
BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells.
Rizo A, Horton SJ, Olthof S, Dontje B, Ausema A, van Os R, van den Boom V, Vellenga E, de Haan G, Schuringa JJ. Rizo A, et al. Among authors: schuringa jj. Blood. 2010 Nov 25;116(22):4621-30. doi: 10.1182/blood-2010-02-270660. Epub 2010 Aug 19. Blood. 2010. PMID: 20724541 Free article.
Bone marrow dysfunction in chronic heart failure patients.
Westenbrink BD, Voors AA, de Boer RA, Schuringa JJ, Klinkenberg T, van der Harst P, Vellenga E, van Veldhuisen DJ, van Gilst WH. Westenbrink BD, et al. Among authors: schuringa jj. Eur J Heart Fail. 2010 Jul;12(7):676-84. doi: 10.1093/eurjhf/hfq061. Epub 2010 Apr 28. Eur J Heart Fail. 2010. PMID: 20427614 Free article.
NUP98 dysregulation in myeloid leukemogenesis.
Moore MA, Chung KY, Plasilova M, Schuringa JJ, Shieh JH, Zhou P, Morrone G. Moore MA, et al. Among authors: schuringa jj. Ann N Y Acad Sci. 2007 Jun;1106:114-42. doi: 10.1196/annals.1392.019. Epub 2007 Apr 18. Ann N Y Acad Sci. 2007. PMID: 17442773 Review.
Inhibition of the transforming growth factor beta (TGFbeta) pathway by interleukin-1beta is mediated through TGFbeta-activated kinase 1 phosphorylation of SMAD3.
Benus GF, Wierenga AT, de Gorter DJ, Schuringa JJ, van Bennekum AM, Drenth-Diephuis L, Vellenga E, Eggen BJ. Benus GF, et al. Among authors: schuringa jj. Mol Biol Cell. 2005 Aug;16(8):3501-10. doi: 10.1091/mbc.e04-11-1033. Epub 2005 May 25. Mol Biol Cell. 2005. PMID: 15917296 Free PMC article.
Two cases of lingual thyroid.
Schuringa J. Schuringa J. Pract Otorhinolaryngol (Basel). 1965;27(5):316-9. doi: 10.1159/000274681. Pract Otorhinolaryngol (Basel). 1965. PMID: 5860286 No abstract available.